What is the prevalence of Marshall syndrome - PFAPA?

Marshall syndrome, commonly referred to as PFAPA syndrome (Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis), is an autoinflammatory condition with an unknown exact prevalence due to significant underdiagnosis and misdiagnosis. While considered a rare or under-recognized pediatric condition, clinical estimates suggest it is the most common cause of periodic fever in children, though exact global population numbers remain elusive in medical literature.

What is the estimated prevalence and incidence of PFAPA syndrome?

Determining the precise prevalence of Marshall syndrome—or PFAPA syndrome—is challenging because there is no mandatory disease registry and many cases are managed by primary care physicians without formal reporting. While often categorized within the umbrella of rare autoinflammatory diseases, some experts argue it is more common than currently diagnosed. Because the condition is often self-limiting and symptoms can be mistaken for recurrent viral infections or streptococcal pharyngitis, the true incidence remains unknown. Data from the DiseaseMaps.org community currently includes 7 individuals who have shared their experiences, providing a small but vital window into the real-world impact of living with this condition.

Does Marshall syndrome affect specific demographics differently?

Clinical observation indicates that Marshall syndrome typically presents in early childhood, most commonly between the ages of 2 and 5 years. Regarding gender distribution, studies generally suggest a slight male predominance, though this can vary across different clinical cohorts. There is no strong evidence linking the condition to specific ethnic or geographic populations, as cases have been reported globally. Unlike many other autoinflammatory syndromes, Marshall syndrome (PFAPA) is currently not considered a hereditary condition in the traditional Mendelian sense, though research into potential genetic predispositions is ongoing.

Why is accurate data on Marshall syndrome so difficult to obtain?

The primary hurdle in calculating the prevalence of Marshall syndrome is the lack of a definitive diagnostic biomarker. Diagnosis is currently based on clinical criteria—specifically the "Marshall criteria"—which include:

• Periodic fever attacks starting before age 5.


• Episodes occurring at regular, predictable intervals.


• Absence of upper respiratory symptoms (aside from pharyngitis).


• Clinical well-being of the child between fever episodes.


• Exclusion of other periodic fever syndromes like Familial Mediterranean Fever (FMF).

What challenges do families face regarding diagnosis?

Because the symptoms of Marshall syndrome often mirror common childhood illnesses, children are frequently subjected to repeated, unnecessary courses of antibiotics. This diagnostic delay can last several years before a specialist, such as a pediatric rheumatologist or immunologist, confirms the diagnosis of PFAPA syndrome. The under-recognition of Marshall syndrome means that many families suffer in isolation, unaware that their child’s recurring fevers follow a recognized clinical pattern.

Next steps

• Consult a pediatric rheumatologist to discuss whether your child’s symptoms meet the clinical criteria for Marshall syndrome.


• Keep a detailed "fever diary" documenting the start, duration, and associated symptoms of each episode to assist your physician in the diagnostic process.


• Connect with the 7 members of the DiseaseMaps.org community living with Marshall syndrome to share experiences and coping strategies.


• Review updated clinical guidelines from organizations like the NIH GARD to stay informed on the latest research regarding PFAPA syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any health concerns or treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): PFAPA Syndrome Overview.


• Orphanet: Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome.


• PubMed/NCBI: "Clinical features and long-term outcome of PFAPA syndrome" (Systematic Review).


• UpToDate: "PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, and adenitis)."